Profile

    Corporate information


    Registration country
    Investment activity status
    Active investor

    Fund terms

    Fund manager
    Fund type

    Funding rounds

    Fund Closing CAD 65,000,000


    USD 54,230,000 (31 Dec 2006)

    Selected investments

    Country Date Notes
    Aerpio Therapeutics Inc
    United States 1 Aug 2012 Series A
    Active
    Sigvion Capital
    United States 1 Apr 2011 Series B
    Altair Therapeutics Inc
    Developing novel therapeutics to treat human respiratory diseases.
    United States 1 Feb 2010
    1 Nov 2009
    Series B
    Repeat investment., Active

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.